Leukemia, Myelodysplasia, Transplantation
Clinical Insights
Using telehealth to deliver palliative care to cancer patients
Dr. Alan Lyss discusses the use of telehealth for palliative cancer care, including results from the REACH PC trial.
Conference Coverage
Prevention of HMA failure a goal for high-risk MDS posttransplant
From the Journals
New cancer drugs may have saved more than 1.2 million Americans
Cancer drugs approved between 2000 and 2016 significantly reduced deaths from the most common cancers in the United States.
From the Journals
Ibrutinib associated with decreased circulating malignant cells and restored T-cell function in CLL patients
From the Journals
Beat AML: Precision medicine strategy feasible, superior to SOC for AML
"The study is changing significantly the way we look at treating patients with AML, showing that precision medicine ... can improve short- and...
Conference Coverage
Are HMAS appropriate for posttransplant maintenance in acute leukemias?
Not yet, hematologist/oncologist tells colleagues at ALF meeting.
Conference Coverage
Novel agents hold promise for frontline AML treatment
Conference Coverage
Novel treatments under study for chronic graft-versus-host disease in allo-HCT
Conference Coverage
Final ASCEND study data: Acalabrutinib beat standard of care for r/r CLL
Feature
Are oncologists ready to confront a second wave of COVID-19?
From the Journals
ESMO offers new clinical practice guideline for CLL